Dr Srinivasa Pothula (Sri)
Dr Srinivasa Pothula (Sri) is currently working as a Research Associate with the Pancreatic Research Group, University of New South Wales, Sydney. His scientific journey started as a veterinary surgeon in India. He moved to the USA and pursued his research career at Texas A & M University for about 5 years, before moving to Australia. Sri completed his PhD on stromal tumour interactions in pancreatic cancer under the supervision of Professor Minoti Apte, OAM at the University of New South Wales, Sydney and continues to work at Ingham Institute for applied Medical Research for UNSW.
Sri has been awarded with prestigious scholarships from Faculty of Medicine and Translational Cancer Research Unit, supported by Cancer Institute- NSW. His research involved development of a novel therapeutic approach targeting a specific pathway (the HGF-c-MET pathway) that mediates stromal-tumour interactions in pancreatic cancer. His work is being recognised internationally as evidenced by publications in leading journals and competitive travel awards from the American Pancreatic Association, International Association of Pancreatology, and the Australasian Pancreatic Club. The findings of these studies have been the basis for the recent successful competitive grant funding.
(Sun 16:00-17:50 Elston Room) Session 8: Pancreas & Cancer - Plenary
(17:30-17:40) GRW036 — Amiloride Analogues as Inhibitors of Human Urokinase Plasminogen Activator & Anti-Pancreatic Cancer Agents
(back to speakers)
|
.jpg)